1Wiley SR,Schooley K,Smolak PJ,et al.Identification and characterization of a new member of the TNF family that induces apoptosis[J].Immunity,1995,3 (6):673-682.
2Pitti RM,Marsters SA,Ruppen S,et al.Induction of apoptosis by Apo-2 ligand,a new member of the tumor necrosis factor cytokine family[J].J Bio Chem,1996,271 (22):12687-12690.
3Spierings DC,De Vries EG,Vellenga E,et al.Tissue distribution of the death ligand TRAIL and its receptors[J].Histochem Cytochem,2004,52 (6):821-831.
4Ruefli-Brasse AA,French DM,Dixit VM.Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase[J].Science,2003,302 (5650):1581-1584.
5Yang F,Shi P,Xi X,et al.Recombinant adenoviruses expressing TRAIL demonstrate antitumor effects on non-small cell lung cancer (NSCLC)[J].Med Oncol,2006,23 (2):191-204.
6Kim CY,Jeong M,Mushiake H,et al.Cancer gene therapy using a novel secretable trimeric TRAIL[J].Gene Ther,2006,13 (4):330-338.
7Georgakis GV,Li Y,Rassidakis GZ,et al.Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldan-amycin in Hodgkin's lymphoma ceils down-regulates Akt kinase,dephosphorylates extracellular signal-regulated kinase,and induces cell cycle arrest and cell death[J].Clin Cancer Res,2006,12 (2):584-590.
8Pietersen AM,van der Eb MM,Rademaker HJ,et al.Specific tumor-cell killing with adenovirus vectors containing the apoptin gene[J].Gene Ther,1999,6(5):882-892.
9Shah K,Tung CH,Yang K,et al.Inducible release of TRAIL fusion proteins from a proapoptotic form for tumor therapy[J].Cancer Res,2004,64 (9):3236-3242.
10Shi J,Zheng DX,Liu YX,et al.Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice[J].Cancer Res,2005,65 (5):1687-1692.
5Lancaster JM,Sayer R,Blanchette C,et al.High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survival[J].Clin Cancer Res,2003,9(2):762.
6Horak P,Pils D,Kaider A,et al.Perturbation of the tumor necrosis factor-related apoptosis-inducing ligand cascade in ovarian cancer:overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5[J].Clin Cancer Res,2005,11(24):8585.
7Abdollahi T,Robertson NM,Abdollahi A,Litwack G.Inhibition of TRAIL-induced apoptosis by IL-8 is mediated by the p38-MAPK pathway in OVCAR3 cells[J].Apoptosis,2005,10(6):1383.
8Wiley SR, Schooley K, Smolak IPJ, Din WS, Huang CP, Nicholl JK, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3(6): 673-82.
9Pitti RM, Marsters SA, Ruppert S, Christopher J. Donahuei, Moore A, et al. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Bioi Chem 1996; 271(22): 12687-90.
10Zhao J, Lu Y, Shen HM. Targeting p53 as a therapeutic strategy in sensitizing TRAIL-induced apoptosis in cancer cells. Cancer Lett 2012; 314(1): 8-23.
